HomeInsights52 Week Low Stocks

Shukra Pharmaceuticals Ltd 52 Week Low

Shukra Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

9.7 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

YEARLOW

₹ 21.29

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Shukra Pharmaceuticals Ltd is ₹ 21.29 as of 22 Nov 24 .

Company Fundamentals for Shukra Pharmaceuticals Ltd

No data available

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202458.9
21 Nov 202458.28
19 Nov 202460.39
18 Nov 202462.68
14 Nov 202465.97
13 Nov 202464.93
12 Nov 202466.36
11 Nov 202469.15
08 Nov 202466.08
07 Nov 202467.87

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Shukra Pharmaceuticals Ltd News Hub

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

08 Nov 202417:22

News

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 ...

Read more

24 Sep 202410:28

News

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company...

Read more

16 Sep 202410:13

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

05 Aug 202410:57

News

Shukra Pharmaceuticals schedules EGM

Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

31 Jul 202417:47

News

Board of Shukra Pharmaceuticals recommends final dividend

Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

30 May 202412:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Shukra Pharmaceuticals Ltd

Why is it important to track the 52-week low of Shukra Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Shukra Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Shukra Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Shukra Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Shukra Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Shukra Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Shukra Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Shukra Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Shukra Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Shukra Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Shukra Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Shukra Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Shukra Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*